Jun 22, 2020
Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity
Jun 09, 2020
Sutro Biopharma to Present New Preclinical Data on its STRO-002 Antibody-Drug Conjugate at the Upcoming AACR 2020 Virtual Meeting on June 22, 2020
May 21, 2020
Sutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller
May 11, 2020
Sutro Biopharma Announces Pricing of $85.3 Million Public Offering
May 11, 2020
Sutro Biopharma Reports First Quarter 2020 Financial Results and Recent Business Highlights and Developments
May 11, 2020
Sutro Biopharma Announces Proposed Public Offering
Apr 13, 2020
Sutro Biopharma to Present Updated Clinical Data for its STRO-002 Antibody-Drug Conjugate at the AACR Virtual Annual Meeting on April 27, 2020
Mar 16, 2020
Sutro Biopharma Reports Full Year 2019 Financial Results and Recent Business Highlights and Developments
Feb 27, 2020
Sutro Biopharma to Present at the Cowen and Company 40th Annual Health Care Conference
Feb 05, 2020
Sutro Biopharma Expands Senior Management Team with the Appointments of Vice President of Immunobiology and Vice President of Business Development
Jan 09, 2020
Sutro Biopharma to Present at 38th Annual J.P. Morgan Healthcare Conference
Jan 08, 2020
Sutro Biopharma Appoints James Panek to Board of Directors
Nov 19, 2019
Sutro Biopharma to Present at the Stifel 2019 Healthcare Conference
Nov 08, 2019
Sutro Biopharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights and Developments
Oct 16, 2019
Sutro Biopharma Announces Presentation of STRO-002 for the Potential Treatment of Ovarian and Endometrial Cancer at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Oct 08, 2019
Sutro Biopharma to Receive Milestone Payment for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors
Sep 04, 2019
Sutro Biopharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference
Aug 14, 2019
Sutro Biopharma Reports Second Quarter 2019 Financial Results and Recent Business Highlights and Developments
Aug 08, 2019
Sutro Biopharma to Present at the 2019 Wedbush PacGrow Healthcare Conference
Jun 24, 2019
Sutro Biopharma Appoints Biopharma Veteran Connie Matsui as Board Chair